Neuro Talk: Early-Onset Parkinson’s Disease (EOPD)

While the symptoms are similar to late or typical-onset PD, such as tremors, stiffness and slowed movement, EOPD can progress more slowly and involve different forms of treatment.

How to Address Sleep Disorders in Parkinson’s for Sounder Slumber

Sleep disturbances can be common in Parkinson’s disease (PD), but getting a good night’s sleep is possible.

Insights from Our Latest Community Survey

In January 2025, the Parkinson’s Foundation asked people living with Parkinson’s disease (PD) and those impacted by it: “What matters most to you?”

Conclusiones de nuestra última encuesta comunitaria

En enero de 2025, la Parkinson's Foundation preguntó a las personas que viven con la enfermedad de Parkinson (EP) y a quienes impacta: "¿Qué es lo que más le importa?"

Meet a Researcher Aiming to Treat Levodopa-induced Dyskinesia

Jeroen Habets, MD, PhD seeks to identify brain wave “biomarkers” of levodopa-induced dyskinesia (LID), highlighting regions of the brain that go awry and the use of magnetic stimulation therapy to reduce or eliminate LID completely.

Take Charge: Self-Advocacy Strategies to Make the Most of Healthcare Visits

Learning to be an active member of your care team — prioritizing your concerns, questions and needs before and during every healthcare appointment — can help you optimize the value of each visit.

Ganando terreno: La búsqueda por mejorar e introducir nuevos medicamentos contra el Parkinson

Study Finds Potential Link Between Parkinson's and Gut Health

Inflammatory bowel disease (IBD) — conditions like Crohn's disease and ulcerative colitis — are linked to an increased risk of developing Parkinson's disease (PD), a neurodegenerative disorder affecting movement.

How PD GENEration Accelerates Clinical Trial Recruitment

Genetic testing can help connect people with Parkinson’s to studies that address specific mutations.

The Latest on The National Parkinson's Project

The National Plan will encompass research, care, and services for Parkinson’s disease (PD) and all other neurodegenerative Parkinsonisms.